Key developments in biotech include a promising gene therapy for deafness showing real-world benefits, while ultra-affordable telehealth services raise concerns about possible impacts on patient care. Additionally, RFK Jr. is taking a new stance on vaccines during congressional testimony. In corporate news, Sanofi faces uncertainty as new CEO Belén Garijo takes over, leading to speculation about possible shifts in the company’s research priorities, especially after unsatisfactory results in immunology.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.statnews.com/2026/04/23/biotech-news-sanofi-research-priorities-in-flux-with-new-ceo/?utm_campaign\u003drss
